[go: up one dir, main page]

ES2055421T3 - Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion. - Google Patents

Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.

Info

Publication number
ES2055421T3
ES2055421T3 ES90903980T ES90903980T ES2055421T3 ES 2055421 T3 ES2055421 T3 ES 2055421T3 ES 90903980 T ES90903980 T ES 90903980T ES 90903980 T ES90903980 T ES 90903980T ES 2055421 T3 ES2055421 T3 ES 2055421T3
Authority
ES
Spain
Prior art keywords
neurodegeneration
prevention
treatment
clormetiazole
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90903980T
Other languages
English (en)
Inventor
Robin Bernard Boar
Alan John Cross
Alfred Richard Green
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2055421T3 publication Critical patent/ES2055421T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymerization Catalysts (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

EMPLEO DE CHLOROMETHIAZOLE EN/O EL TRATAMIENTO DE LA NEURODEGENERACION.
ES90903980T 1989-02-17 1990-02-13 Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion. Expired - Lifetime ES2055421T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900564A SE8900564D0 (sv) 1989-02-17 1989-02-17 Novel medicinal use

Publications (1)

Publication Number Publication Date
ES2055421T3 true ES2055421T3 (es) 1994-08-16

Family

ID=20375091

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90903980T Expired - Lifetime ES2055421T3 (es) 1989-02-17 1990-02-13 Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.

Country Status (16)

Country Link
EP (1) EP0458892B1 (es)
JP (1) JP3007683B2 (es)
KR (1) KR0139221B1 (es)
AT (1) ATE107166T1 (es)
AU (1) AU643431B2 (es)
CA (1) CA2045618A1 (es)
DE (1) DE69009989T2 (es)
DK (1) DK0458892T3 (es)
ES (1) ES2055421T3 (es)
HK (1) HK44597A (es)
IE (1) IE64622B1 (es)
IL (1) IL93243A (es)
NZ (1) NZ232499A (es)
PH (1) PH26372A (es)
SE (1) SE8900564D0 (es)
WO (1) WO1990009174A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS1688B (is) * 1991-10-30 1998-04-20 Ab Astra Ný aðferð við framleiðslu 4-metýl-5-(2-klóróetýl)-þíasól og hliðstæðum þess og ný milliefni við framleiðslu efnasambandanna
SE9802119D0 (sv) * 1998-06-15 1998-06-15 Astra Ab New use
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE196140C1 (es) * 1964-01-01

Also Published As

Publication number Publication date
IL93243A0 (en) 1990-11-29
DE69009989D1 (de) 1994-07-21
KR920700641A (ko) 1992-08-10
JP3007683B2 (ja) 2000-02-07
HK44597A (en) 1997-04-18
IE64622B1 (en) 1995-08-23
PH26372A (en) 1992-06-01
SE8900564D0 (sv) 1989-02-17
KR0139221B1 (en) 1998-05-15
CA2045618A1 (en) 1990-08-18
EP0458892B1 (en) 1994-06-15
DK0458892T3 (da) 1994-08-15
AU5167990A (en) 1990-09-05
AU643431B2 (en) 1993-11-18
ATE107166T1 (de) 1994-07-15
EP0458892A1 (en) 1991-12-04
NZ232499A (en) 1992-12-23
IE900460L (en) 1990-08-17
IL93243A (en) 1994-08-26
DE69009989T2 (de) 1994-10-13
WO1990009174A1 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
ES2018706B3 (es) Composicion polimera, un procedimiento para obtener una composicion polimera y el uso de dicha composicion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
MX25231A (es) Compuestos de carbapenem y procedimiento para su preparacion.
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
ES2087279T3 (es) El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9405371A (es) Derivado de naftilo.
ES2055421T3 (es) Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.
MX9205821A (es) Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion.
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
PT804199E (pt) Uso de penciclovir para o tratamento de nevralgias pos-herpeticas
SE8802040D0 (sv) New use
AR240479A1 (es) Un agente de curtido de cueros y el procedimiento para curtir.
ES2022271B3 (es) Periplanon a, procedimiento para la elaboracion y su aplicacion para el tratamiento de rascados
MX9202250A (es) Compuestos de penem y procedimiento para su preparacion.
MX15982A (es) Compuestos hidrosolubles de ftalocianina y procedimiento para su preparacion.
ES1011387Y (es) Protesis para el tratamiento y recuperacion de miembros inferiores.
MX9102721A (es) Procedimento para la prepacion de arilquilaminas y arilquilaminas substituidas.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
MX17601A (es) Composicion para el tratamiento de leishmaniasis yprocedimiento para su preparacion .

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 458892

Country of ref document: ES